Merck And Co Inc Drug Patent Portfolio

Merck And Co Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Merck And Co Inc News

Merck & Co. Inc.: The Transformation of a 130-Year-Old Pharmaceutical Leader Focusing on Cancer Treatment

05 Jan, 2026

Merck to Discuss Patent Expirations and Drug Development Plans at JP Morgan Conference...

01 Jan, 2026

FDA Accelerates Approval Process for Two Promising Merck (MRK) Medications - Finviz

30 Dec, 2025

FDA Accelerates Approval Process for Two Promising Merck (MRK) Medications - Yahoo Finance

30 Dec, 2025

See More